Blood procured in name of one patient, given to another: FDA cancels Mumbai cancer hospital’s storage licence | Mumbai News


Blood procured in name of one patient, given to another: FDA cancels Mumbai cancer hospital’s storage licence

Mumbai: Food and Drug Administration (FDA) has cancelled the licence of the blood storage centre at Punyashlok Ahilyadevi Holkar Head & Neck Cancer Institute of India (HNCII Cancer Hospital) in Byculla. An FDA investigation found that the centre procured blood from JJ Mahanagar Blood Bank in the name of one patient—rather than the storage centre—and then supplied it to another.Moreover, FDA officials said the HNCII storage centre procured blood from its “mother blood banks”, JJ Mahanagar and Badlapur’s Maya Blood Bank, after both had their licences cancelled.Inspections of JJ Mahanagar and Maya Blood Bank were conducted on June 22 and June 23, following which stop-activity notices and licence cancellations were issued. Severe quality lapses were found at both facilities.However, according to FDA, just days later—on June 25 and June 26—the HNCII storage centre procured five units from Maya Blood Bank and one unit from JJ Mahanagar.“For instance, the records show that a B-positive blood bag was issued by JJ Mahanagar in the name of patient Riya Verma. HNCII confirmed that it was received, but then issued it to Kishore Sahoo,” said a drug department official.Explaining the standard protocol, a doctor in charge of a BMC-run blood bank said cancer surgeries can cause severe bleeding; this is why hospitals keep extra blood on standby. If those reserved units go unused, they can be reallocated to another patient after proper cross-matching.However, when a storage centre procures blood in a patient’s name, the BMC doctor said that patient pays the mother blood bank directly instead of the hospital covering the stock cost. If that unit is not used for Patient A, the storage centre can double-charge by billing Patient B for the exact same bag of blood that was already paid for. “So the question is if the patients who paid for the unit get refunded in case the blood they procured was not used for their treatment,” said the doctor.While Reshma Naidu, executive trustee at HNCII, did not answer why the blood was procured in the name of one patient instead of the storage centre—and then given to another—she told TOI that the storage centre was managed by Dr Hitesh Pagare, who also managed JJ Mahanagar Blood Bank.“It was in our premises and for our patients but we were not involved in the day-to-day operations. Now we have come to a realisation it cannot be taken for granted. We have verified all the safety checks and are taking corrective actions,” Naidu said.FDA officials also added that even as the blood storage centre was not managed by the hospital, it was the hospital staff itself that was running it. “Moreover, the medical and technical staff who was deployed there had no FDA approval,” said the FDA official.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *